Edition:
India

Merit Medical Systems Inc (MMSI.OQ)

MMSI.OQ on NASDAQ Stock Exchange Global Select Market

29.40USD
11:07pm IST
Change (% chg)

$0.65 (+2.26%)
Prev Close
$28.75
Open
$28.90
Day's High
$30.46
Day's Low
$28.69
Volume
232,752
Avg. Vol
199,789
52-wk High
$66.28
52-wk Low
$25.71

Summary

Name Age Since Current Position

Fred Lampropoulos

69 1987 Chairman of the Board, President, Chief Executive Officer

Raul Parra

41 2018 Chief Financial Officer, Treasurer

Joseph Wright

49 2015 President - International Division

Ronald Frost

57 2014 Chief Operating Officer

Justin Lampropoulos

36 2015 Executive Vice President - Sales, Marketing and Strategy

Brian Lloyd

58 2016 Chief Legal Officer, Corporate Secretary

Nolan Karras

74 2017 Lead Independent Director

Jill Anderson

59 2019 Director

Kent Stanger

64 2015 Director

Lynne Ward

61 2019 Director

A. Scott Anderson

72 2011 Independent Director

Thomas Gunderson

68 2017 Independent Director

David Liu

45 2016 Independent Director

Franklin Miller

78 2005 Independent Director

F. Ann Millner

67 2015 Independent Director

Anne-Marie Wright

Vice President - Corporate Communications

Biographies

Name Description

Fred Lampropoulos

Mr. Fred P. Lampropoulos is Chairman of the Board, President, Chief Executive Officer of the Company. He served as Chair of the Board, CEO and President of the Company since its formation in 1987 Chair of the Board and President of Utah Medical Products, Inc. (medical device manufacturer), 1983 to 1987 Filed more than 200 domestic and international patents and applications on medical devices Serves on several community and advisory boards Recipient of numerous community and industry awards, including 2003 and 2018 Utah Governor’s Medal for Science and Technology. The Board believes the Company benefits immensely from Mr. Lampropoulos’ experience as founder, President and Chief Executive Officer. He plays an essential role in communicating the expectations, advice, concerns and encouragement of the Board to our employees. Mr. Lampropoulos has a deep knowledge and understanding of the Company, as well as the industry and markets in which our products compete. Mr. Lampropoulos also performs an essential function as the Chair of the Board, providing decisive leadership and direction to the activities and deliberations of the Board. The Board also believes Mr. Lampropoulos’ leadership, drive and determination are significant factors in our growth and development and continue to be tremendous assets to the Company and its shareholders.

Raul Parra

Mr. Raul Parra, Jr. is Chief Financial Officer, Treasurer of the Company. He Previous positions at Merit include Interim CFO, Vice President of Accounting, Corporate Controller, Director of Financial Reporting Before joining Merit, held various audit positions at Deloitte & Touche, LLP. B.S. (business administration with accounting emphasis), Sonoma State; Certified Public Accountant (CPA).

Joseph Wright

Mr. Joseph C. Wright is President - International Division of the Company. He Previous positions at Merit include (a) President, Technology Group – overseeing Merit OEM, Merit Sensor Systems, Inc. and Merit’s coating division, (b) Vice President of Marketing, and (c) Vice President, International – responsible for sales in Canada, Asia Pacific, and Latin America, 2005 to 2015 Manages businesses in all global markets outside the U.S. and Europe, Middle East and Africa Before joining Merit, held sales, marketing and business development positions with several companies, including Motorola and Micron. B.A., (political science), Columbia University; M.B.A., (finance) Columbia University; Speaks Japanese. Mr. Wright is the brother-in-law of Fred P. Lampropoulos, Merit’s CEO, President and Chair of the Board

Ronald Frost

Mr. Ronald A. Frost is Chief Operating Officer of the Company. He has More than 27 years of service to Merit and its shareholders Previous positions at Merit include Vice President (Materials and Operations), Quality Engineer, Manufacturing Engineer, Custom Kits Manager, Customer Service Manager, Production Planning and Warehouse Manager, General Manager of our Richmond, Virginia operations, and Vice President (Technology Transfer), 1991 to 2014. Manufacturing Engineering Technology, AAS, Machine Tooling, Weber State University.

Justin Lampropoulos

Mr. Justin J. Lampropoulos is Executive Vice President - Sales, Marketing and Strategy of the company. He From 2010 to 2015 lead Merit’s Europe, Middle East and Africa business unit from Maastricht, The Netherlands Began his career in the medical device technology field in 2004. Completed postgraduate studies at Oxford University’s Saïd Business School in Oxford, England in strategic management and is an alumnus of Harvard Business School. Mr. Justin J. Lampropoulos is the son of Fred P. Lampropoulos, Merit’s Chair of the Board, CEO and President.

Brian Lloyd

Mr. Brian G. Lloyd is Chief Legal Officer, Corporate Secretary of the Company. Practiced as an attorney, specializing in corporate governance, securities regulation and mergers & acquisitions, with the law firm of Parr Brown Gee & Loveless in Salt Lake City, Utah for more than 20 years Also practiced law in those areas of specialization as a partner with the law firm of Stoel Rives, LLP for four years. B.S. (finance), Brigham Young University; J.D., Columbia Law School.

Nolan Karras

Mr. Nolan E. Karras serves as Lead Independent Director of the Company. He was Chair and CEO of The Karras Company, Inc. (investment advisory firm), 1997 to present Chair and Member of Board of Trustees of Weber State University (chair of audit committee), 2013 to present Chair of Utah Governor’s Education Excellence Commission, 2015 to 2018 Community Board of Directors of University of Utah Hospitals and Clinics (chair of finance committee), 2009 to 2014 CEO of Western Hay Company, Inc. (agricultural products company), 1995 to 2012, and director, 1995 to 2018) Board of Directors of Beneficial Life Insurance Company (privately-held life insurance company) (chair of finance committee and member of executive committee), 1996 to 2009, Member of the Utah State Board of Regents, 2001 to 2013 (chair, 2002 to 2006) Former director and member of audit and compensation committees of boards of directors of PacifiCorp (a public utility operating in the northwestern United States) and Scottish Power (multinational energy company) Several positions in public service, including ten years as Speaker of the House and House Majority Leader of the Utah House of Representatives. Mr. Karras’ experience and skills qualify him to work constructively with our management and directors, especially in connection with our pursuit of growth and expansion opportunities. The Board believes Mr. Karras’ financial acumen and experience in corporate governance are valuable to its deliberations and strategic planning and in his service as Chair of the Audit Committee. Mr. Karras also has a keen awareness of the social, political and economic environments in which the Company’s principal facilities are located.

Jill Anderson

Ms. Jill D. Anderson has been appointed as Director of the company effective January 1, 2019. She served as the President, Chief Executive Officer and Director of Cianna Medical from January 2008 until the Company’s acquisition of Cianna Medical in November 2018 President of BioLucent, Inc. from May 2001 to September 2007 Previously served on the Board of Directors for Mammoplan LLC, and Solis Women’s Health. Ms. Anderson is a healthcare executive with more than 18 years of experience leading the innovation, development and commercialization of medical devices. The Board believes she brings innovative thinking and creative problem solving to addressing complex business problems in the search for growth opportunities. Ms. Anderson is skilled in building executive-level teams, commercializing breakthrough technologies, strategic planning, market strategy, company and product branding, marketing and communications. Her entrepreneurial nature and commitment to patient care has contributed to the development and successful exit of two venture-backed medical device companies and the organization and operation of several for-profit and not-for-profit comprehensive cancer centers.

Kent Stanger

Mr. Kent W. Stanger is Director of the Company. He is Member of Board of Directors and Executive Committee of Utah Taxpayers Association, 2012 to 2016 Chief Financial Officer, Secretary and Treasurer of the Company, 1987 to 2015 Controller of Utah Medical Products, Inc. (medical device manufacturer), 1985 to 1987 Corporate Controller for Laser Corporation, American Laser and Modulaire Industries, Inc., 1982 to 1985 Hansen, Barnett and Maxwell (former Utah accounting firm that merged with Eide Bailly LLP in 2013) as practicing certified public accountant, 1979 to 1982. Mr. Stanger was a founder of the Company and, through more than 27 years of service as the principal financial manager of the Company, developed a broad understanding of our business and operations, as well as the industry and markets in which the Company competes. The Board values Mr. Stanger’s accounting and financial management skills and benefits greatly from his extensive knowledge of our history, achievements, competitive position and strategic objectives.

Lynne Ward

Ms. Lynne N. Ward is Director of the Company. Ms. Ward, is currently serving as the Executive Director of my529 (formerly Utah Educational Savings Plan), a Utah state-run college savings plan offering municipal fund securities, a position she has held since 2004. Prior to her appointment with my529, Ms. Ward served as Deputy Chief of Staff to former Utah Governor Olene S. Walker and Director of the Governor’s Office of Planning and Budget under former Utah Governor Michael O. Leavitt. The Board believes Ms. Ward possesses specific attributes that qualify her to serve as a director of the Company, including her years of experience in strategy, business execution and organizational leadership, as well as her oversight of financial and accounting practices.

A. Scott Anderson

Mr. A. Scott Anderson is Independent Director of the Company. He is the President and CEO of Zions First National Bank (commercial bank based in the intermountain U.S.), 1990 to present Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (Chair, 2012 to 2018) Director of the Federal Reserve Bank of San Francisco (Salt Lake City Branch), 2003 to 2008. Mr. Anderson contributes to the Board’s deliberations more than 40 years of experience in the banking and financial services industries. The Board believes Mr. Anderson provides insight regarding national and international financial and credit markets, as well as lending practices, which are valuable as we continue to implement our growth strategy. Mr. Anderson also contributes extensive business and corporate governance experience to the strategic planning and operational discussions of the Board. Mr. Anderson’s business and corporate governance experience have been instrumental in the deliberations of our Compensation Committee, which he chairs, and the development of our executive compensation practices.

Thomas Gunderson

Mr. Thomas Gunderson serves as Independent Director of the Company. Mr. Gunderson is the Chair of the Board of Directors of the Minneapolis Heart Institute Foundation, 2015 to present Executive in Residence at the University of Minnesota’s Medical Industry Leadership Institute, 2016 to present Member of American Heart Association Science and Technology Accelerator Committee, 2015 to 2017 Managing Director and senior research analyst at Piper Jaffray (focus on medical technology companies), 1992 to 2016 Project Director at American Medical Systems (private medical device company acquired by Pfizer in 1983), 1979 to 1992 Recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, Thomson Reuters, and Medical Device and Diagnostic Industry (e.g., in 1996 and 2000, he was named an All-Star Analyst for medical stocks by the Wall Street Journal and in 2014, Thomson-Reuters named him “Top Stock Picker” in the medical technology sector). Mr. Gunderson provides the Board with more than 25 years of substantive experience in the medical device industry, with a seasoned perspective on the challenges, trends and opportunities of publicly-traded medical device manufacturers, as well as a keen understanding of the Company’s competitive position within its industry. Mr. Gunderson also contributes a strong background in financial and economic analysis and valuable insights regarding business development and acquisition opportunities. Mr. Gunderson’s financial background and industry experience have been beneficial in his service as the Chair of our newly-established Finance Committee.

David Liu

Dr. David Ming-Teh Liu is Independent Director of the Company. He is an Interventional radiologist (certified in the U.S. and Canada), practicing at the Vancouver General Hospital, University of British Columbia Hospital, and BC Cancer Agency (with cross appointment in surgery department), 2008 to present Clinical Associate Professor of Radiology at the University of British Columbia, 2008 to present Medical Director at Eva Vein Care (team of physicians specializing in diagnostic assessment, endovascular therapy and interventional radiology), 2012 to present Co-founder and co-chair of the symposium on Hepatic Oncology at Whistler, an international liver cancer symposium Credited with 7 book chapters, over 60 publications, and 100 invited lectures around the world Inducted Fellow of the Society of Interventional Radiology. In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer-related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating multiple aspects of embolization, ablation, venous access and palliative therapy in organ systems. Fluent in Mandarin, Dr. Liu is an active member of the interventional radiology community and has served as an advisor on multiple global advisory boards and technology development committees for various scientific and commercial organizations. The Board believes Dr. Liu’s extensive industry experience, scientific credentials and active clinical practice provide him with vital insights into the trends, risks and opportunities in many of our core interests. Dr. Liu also contributes valuable clinical and industry perspective to the Board’s analysis of prospective acquisitions, product development and other strategic decisions.

Franklin Miller

Dr. Franklin J. Miller is Independent Director of the Company. He is Consultant to the Company, assisting in product testing and development, 1997 to 2005 Professor of Radiology and Surgery at the University of Utah Department of Radiology, 1976 to 2005 (Director of Interventional Radiology, 1976 to 2001) Clinical Professor of Radiology at the University of California, San Diego (began the Hereditary Hemorrhagic Telangiectasia Clinic, one of only eight such clinics in the United States), 2002 to 2011 Served on advisory boards to several medical device companies and member of editorial and review boards for numerous medical journals. Dr. Miller contributes a valuable set of skills, training and experience to the Board’s deliberations. During his service as a director, Dr. Miller has provided significant advice regarding our product development strategy

F. Ann Millner

Dr. F. Ann Millner, Ed.D. is Independent Director of the Company. She has served as Regents Professor and Professor of Health Administrative Services at Weber State University, 2013 to present Member of the Utah State Senate (member of multiple committees and subcommittees), 2015 to present Member of Utah Governor’s Task Force on Educational Excellence, 2015 to present Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (serving as Vice Chair, 2017 to present) President of Weber State University, 2002 to 2012 (first female president of a Utah state university) Vice President of University Relations at Weber State University, 1993 to 2002 Associate Dean of Continuing Education and Assistant Vice President of Community Partnerships at Weber State University, 1985 to 1993. The Board believes Dr. Millner’s qualifications to serve as a director of the Company include her executive leadership skills and her experience in the areas of organizational administration, operations and financial management, and business strategy. Those skills and experience have been particularly valuable to the Company in the course of Dr. Millner’s service as the Chair of our Governance Committee. During her service as the Chair of our Governance Committee, Dr. Millner has played a significant role in the development of our corporate governance practices and engagement with our shareholders.

Anne-Marie Wright

Basic Compensation